Continue
By using our website you accept our cookies policy.Find out more

KTN’s Dr. Sarah Goulding to be awarded the Richard Wilson Impact Award at the bioProcessUK Conference

Posted on 14/11/2019

It has been announced that Dr. Sarah Goulding will receive the prestigious award at next month’s conference in Liverpool.

Knowledge Transfer Network’s Specialist in Advanced Therapies and Medicines, Dr. Sarah Goulding, will be awarded the Richard Wilson Impact Award at the UK BioIndustry Association’s (BIA) bioProcessUK Conference in Liverpool at the end of November in recognition of her contribution to the bioprocessing and biologics manufacturing sector. The Richard Wilson Impact Award acknowledges those who are making a significant impact on the bioprocessing sector and is named in honour of Richard Wilson, who was the co-inventor of the Lonza GS system. The BioIndustry Association announced Dr. Sarah Goulding as the winner in a press release on 13th November.

 

Sharon Grimster of ReNeuron will additionally receive the Peter Dunnill award at the same conference also in recognition of her work in the bioprocessing sector.

 

Steve Bates OBE, Chief Executive of the BIA said: “I’m delighted that Sharon and Sarah are receiving these awards, this is recognition of their hard work over many years in helping build the vibrant and world leading UK bioprocessing sector we have today. They have been trailblazers in the bioprocessing sector and their work in bringing together the different parts of the ecosystem has greatly benefitted the UK sector, companies and patients.”

 

Dr. Sarah Goulding said: “I am surprised, delighted and very humbled to receive this award from peers at bioProcessUK. It is a privilege to work with a community that is so welcoming, energetic and passionate about making a difference in how we manufacture the medicines of the future.”

 

The 16th bioProcessUK Conference will take place at St. George’s Hall in Liverpool on 27th – 28th November 2019 with the theme of ‘Bioprocessing in the Digital Age’. Last year’s conference welcomed 285 delegates from 160 leading organisations, with 2019 shaping up to be another success where attendees can hear about the latest news and developments within the manufacturing and biologics arena. The conference aims to be the lead showcase event for biopharmaceutical innovation and will be made up of keynote presentations, focused workshops, exhibition, 1-1 speed-partnering and the popular networking conference dinner. Delegate passes and press passes are still available – please click here for more information.

 

The BioIndustry Association (BIA) was established over 25 years ago and is the trade association for innovative life sciences in the UK. BIA’s goal is to secure the UK’s position as a global hub and as the best location for innovative research and commercialisation, enabling the country’s world-leading research base to deliver healthcare solutions that can truly make a difference to people’s lives. Visit their website here.